GENB · Company research
Generate Biomedicines, Inc. Common Stock (GENB): Valuation Analysis
Available valuation snapshots and ratios; unavailable metrics remain blank.
RESEARCH CONTEXT
Understand the numbers
Available valuation snapshots and ratios; unavailable metrics remain blank. Use period, currency, units and source fields when interpreting values.
1records availableHealthcare
Valuation Analysis data
Database-backed records only
| valuation date | price | market cap | enterprise value | pe | forward pe | peg | price sales | price book | price fcf |
|---|---|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | 13.57 | $1,912,063,931.61 | 1776704931.61 | — | — | — | 302.8292574611973392 | 4.1927089028714272 | — |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.